Back to Trials
NCT06949644NARecruiting

Pupillometry in Delayed Sleep Wake Phase Disorder

Northwestern University

Start Date

9/1/2025

Completion Date

8/31/2029

Summary

The goal of this observational study is to characterize the pupil light response in patients with delayed sleep-wake phase disorder. A subset of participants will take part in a clinical trial to determine if increasing serotonin can alter the circadian response to light. The main questions it aims to answer is: Are there differences in the light response in patients with delayed sleep-wake phase disorder? Does citalopram increase melatonin suppression in patients with delayed sleep-wake phase disorder? Participants will complete activity and melatonin testing at home to determine their circadian timing. This will be followed by an eye test looking at the pupil response to different light stimuli. A subset of participants will complete two inpatient admissions where melatonin levels will be sampled and they will be exposed to a bright light. During one round of testing they will receive a placebo and in the other round of testing they will take a single dose of citalopram, a selective serotonin reuptake inhibitor.

Eligibility Criteria

Age Range: 16 years to No maximum

Inclusion Criteria: * Delayed sleep-wake phase disorder Exclusion Criteria: * Use of medications known to alter pupil diameter * History of eye disease or eye surgery * Unstable medical or psychiatric condition * Shift work or self imposed irregular sleep schedules * Caffeine consumption \>400mg/day

Interventions

COMBINATION_PRODUCT

Light and Citalopram

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Delayed Sleep-Wake Phase Disorder

Locations

Northwestern University

Chicago, Illinois 60611

United States